Armenia vs Czechia: The number of people with susceptibility test result for rifampicin
Armenia
209
in 2021
Czechia
239
in 2021
Armenia rank
93rd
Czechia rank
90th
The number of people with susceptibility test result for rifampicin over time
- Armenia
- Czechia
How they compare
Czechia currently reports 239 against 209 in Armenia, a difference of 30.
That makes Czechia's figure about 1.1 times Armenia's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Armenia ahead.
Armenia ranks 93rd and Czechia ranks 90th of 155 countries.
Czechia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Armenia | Czechia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 267.67 | 294 | 26.33 | Czechia |
| 2020s | 203.5 | 231 | 27.5 | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Armenia or Czechia?
- Czechia, at 239 against 209 in Armenia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Armenia and Czechia?
- 30, with Czechia ahead.
- How many years of comparable data are there for Armenia and Czechia?
- 5 years are reported by both, from 2017 to 2021.
- How do Armenia and Czechia rank globally for the number of people with susceptibility test result for rifampicin?
- Armenia ranks 93rd and Czechia ranks 90th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.